Proteinuria after intravesical chemotherapy.
D002272:Carcinoembryonic Antigen / Q000652:urine*; D002278:Carcinoma in Situ / Q000188:drug therapy* / Q000652:urine; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use*; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D011507:Proteinuria / Q000139:chemically induced*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000652:urine
D002272:Carcinoembryonic Antigen; D008937:Mitomycins; D016685:Mitomycin; D004317:Doxorubicin